Literature DB >> 26822901

High susceptibility prevalence for F4+ and F18+Escherichia coli in Flemish pigs.

Ut V Nguyen1, Annelies Coddens2, Vesna Melkebeek3, Bert Devriendt4, Tiphanie Goetstouwers5, Mario Van Poucke6, Luc Peelman7, Eric Cox8.   

Abstract

F4 and/or F18 enterotoxigenic Escherichia coli (F4+/F18+ ETEC) are responsible for diarrhea while F18+ verotoxigenic E. coli (F18+ VTEC) cause edema disease in pigs. Both infections can result in severe economic losses, which are mainly the result of the medication, growth retardation and mortality. The susceptibility of piglets to these pathogens is determined by the presence of F4 and F18 receptors (F4R and F18R). Understanding the composition of the susceptibility phenotypes of pigs is useful for animal health and breeding management. This study aimed to determine the prevalence of the F4 ETEC susceptibility phenotypes and F18+E. coli susceptibility among Flemish pig breeds by using the in vitro villous adhesion assay. In this study, seven F4 ETEC susceptibility phenotypes were found, namely A (F4abR+,acR+,adR+; 59.16%), B (F4abR+,acR+,adR-; 6.28%), C (F4abR+,acR-,adR+; 2.62%), D (F4abR-,acR-,adR+; 6.28%), E (F4abR-,acR-,adR-; 24.08%), F (F4abR+,acR-,adR-; 1.05%) and G (F4abR-,acR+,adR-; 0.52%). F4ab and F4ac E. coli showed a stronger degree of adhesion to the intestinal villi (53.40% and 52.88% strong adhesion, respectively), compared to F4ad E. coli (43.46% strong adhesion). Furthermore, the correlation between F4ac and F4ab adhesion was higher (r=0.78) than between F4ac and F4ad adhesion (r=0.41) and between F4ab and F4ad adhesion (r=0.57). For F18+E. coli susceptibility, seven out of 82 pigs were F18R negative (8.54%), but only two of these seven pigs (2.44%) were also negative for F4R. As such, the chance to identify a pig that is positive for a F4 ETEC variant or F18+E. coli is 97.56%. Therefore, significant economic losses will arise due to F4+ and/or F18+E. coli infections in the Flemish pig population due to the high susceptibility prevalence.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  F18(+)E. coli; F4 ETEC; Pigs; Post-weaning diarrhea

Mesh:

Substances:

Year:  2016        PMID: 26822901     DOI: 10.1016/j.vetmic.2016.01.014

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Significance of Mucosa-Associated Microbiota and Its Impacts on Intestinal Health of Pigs Challenged with F18+ E. coli.

Authors:  Marcos Elias Duarte; Sung Woo Kim
Journal:  Pathogens       Date:  2022-05-17

2.  Molecular characteristics of fluoroquinolone-resistant Escherichia coli isolated from suckling piglets with colibacillosis.

Authors:  Kwangwon Seo; Kyung-Hyo Do; Wan-Kyu Lee
Journal:  BMC Microbiol       Date:  2022-09-15       Impact factor: 4.465

3.  Pathogenic Escherichia coli-Specific Bacteriophages and Polyvalent Bacteriophages in Piglet Guts with Increasing Coliphage Numbers after Weaning.

Authors:  Yan Lin; Bei Zhou; Weiyun Zhu
Journal:  Appl Environ Microbiol       Date:  2021-08-11       Impact factor: 4.792

4.  Combined Analysis of DNA Methylome and Transcriptome Reveal Novel Candidate Genes Related to Porcine Escherichia coli F4ab/ac-Induced Diarrhea.

Authors:  Wenwen Wang; Chuanli Zhou; Hui Tang; Ying Yu; Qin Zhang
Journal:  Front Cell Infect Microbiol       Date:  2020-05-29       Impact factor: 5.293

Review 5.  How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions.

Authors:  Lynda Mottram; Subhra Chakraborty; Eric Cox; James Fleckenstein
Journal:  Vaccine       Date:  2019-01-29       Impact factor: 3.641

6.  Transcriptomic Study of Porcine Small Intestine Epithelial Cells Reveals Important Genes and Pathways Associated With Susceptibility to Escherichia coli F4ac Diarrhea.

Authors:  Serafino M A Augustino; Qinglei Xu; Xueqin Liu; Lei Liu; Qin Zhang; Ying Yu
Journal:  Front Genet       Date:  2020-02-27       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.